The initial public offering (IPO) market continued at its red hot pace last week with 18 traditional IPOs listing on U.S. markets, marking the fourth week this year with at least 17 listings--the most since 2000.

In the week's largest offering, Ryan Specialty Group Holdings, Inc. (RYAN  ) raised more than $1.3 billion by pricing its shares at its midpoint. The company assists in the placement of hard-to-place risks for retail brokers, as well as the sourcing, onboarding, underwriting, and servicing of those risks. The stock ended the week up 22%.

In the week's best performance, AbSci Corp. (ABSI  ) finished the week up 43% after raising $200 million in its debut by pricing shares at its midpoint. The protein therapy biotech currently has nine active programs across seven partners, including Merck (MRK  ) and Astellas (ALPMY  ), with licence agreements pending.

Here's the rest of the week's debuts in order of offering amount:

Core & Main, Inc. (CNM  ) priced its shares at the low end of its range to raise $698 million. The company distributes water infrastructure products that connect 4,500 suppliers to over 60,000 municipal, non-residential, and residential customers. The stock finished the week up 19%.

Paycor HCM, Inc. (PYCR  ) priced shares above its range to raise $426 million. The company provides human capital management software to SMBs, aiding in the payroll process and key Human Resources functionality. The stock ended the week up 17%.

VTEX (VTEX  ) priced its shares above the range to raise $361 million. The Latin American company operates a business-to-consumer e-commerce platform for enterprise customers that natively combines commerce, order management, and marketplace functionality. The stock ended the week up 34%.

Caribou Biosciences, Inc. (CRBU  ) priced its upsized offering at the high end to raise $304 million. The gene editing biotech is using its novel CRISPR platform to develop genome-edited allogenic cell therapies. Caribou's lead program is currently in a Phase 1 trial for relapsed or refractory B cell non-Hodgkin lymphoma. The stock finished up 2%.

Cytek BioSciences, Inc. (CTKB  ) priced its upsized offering at the midpoint to raise $285 million. The company's core products--the Aurora and Northern Lights systems--offer full spectrum flow cytometers that deliver high-resolution cell analysis. The stock ended the week up 10%.

Instructure Holdings, Inc. (INST  ) priced shares at the midpoint to raise $250 million. The boasts that it is the LMS market leader in both higher education and paid K-12, with over 6,000 global customers across 90 countries. The stock finished up 2%.

SOPHiA GENETICS SA (SOPH  ) priced shares at the midpoint to raise $234 million. The Swiss health tech company provides a cloud-based Software-as-a-Service platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The stock finished down 7%.

CS Disco, Inc. (LAW  ) priced shares above its upwardly revised range to raise $224 million. The legal software provider offers a cloud-native, AI-powered platform that simplifies the legal process and case management. The stock finished up 40%.

Couchbase, Inc. (BASE  ) priced its upsized offer above the range to raise $200 million. The company provides a NoSQL database that enables enterprises and developers to build and run applications across the cloud, on-premise, hybrid, or mobile and edge environments. The stock ended the week up 42%.

Outbrain, Inc. (OB  ) priced shares below the range to raise $160 million. The content marketing platform helps engage users and monetize visits by gathering over 1 billion data events each minute. The stock finished the week flat.

Kaltura, Inc. (KLTR  ) priced shares at the midpoint to raise $150 million. The company provides live, real-time, and on-demand video products to a wide range of businesses, including educational institutions, as well as media and telecom companies. The stock finished the week up 18%.

Zevia PBC (ZVIA  ) priced its downsized offering at its midpoint to also raise $150 million. The beverage brand provides six product lines of zero calorie, zero sugar, naturally sweetened drinks in the United States and Canada. The stock finished the week down 2%.

Zenvia, Inc. (ZENV  ) priced its shares at the low end to also raise $150 million. The Brazilian company's software platform facilitated the flow of communication for more than 10,000 customers throughout Latin America as of March 31, 3021. The stock ended the week down 22%.

Xponential Fitness, Inc. (XPOF  ) priced its downsized offer below the range to raise $120 million. The company is the largest boutique fitness franchisor in the United States with over 1,750 studios operating across nine distinct brands. The company finished up 2%.

HCW Biologics, Inc. (HCWB  ) priced its shares at the low end to raise $56 million. The immunotherapy biotech's lead candidate is currently being evaluated for generation of memory-like NK cell products in two ongoing Phase 2 trials for relapsed/refractory acute myeloid leukemia, with preliminary data expected in the second half of this year. The stock ended the week down 35%.

Gambling.com Group, Ltd. (GAMB  ) priced shares at the low end of its downwardly revised range to raise $42 million. The company offers performance marketing and digital marketing services exclusively for the online gambling industry, with focus on iGaming and sports betting. The stock ended the week flat.